Jane Street Group, LLC Coherus Bio Sciences, Inc. Put Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$10.92 - $16.41 $187,824 - $282,252	17,200 Added 65.9%	43,300 $559,000
Q3 2021 Nov 16, 2021	SELL	$12.68 - $17.79 $20,288 - $28,464	-1,600 Reduced 5.78%	26,100 $419,000
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $128,205 - $152,559	9,900 Added 55.62%	27,700 $383,000
Q1 2021 May 18, 2021	BUY	$14.42 - $21.39 $256,676 - $380,742	17,800 New	17,800 $260,000

130

67.8M

1.68M

91.8K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $83.2M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.